Kim et al. reported that IFN-γ-primed MSCs are correlated with the induction of IDO expression in MSCs via the IFN-γ-JAK-STAT1 pathway, which suppresses T-cell proliferation during GvHD treatment [23]. Here, STAT1 is linked to graft versus host disease.